INTRODUCTION
Several experimental models are able to reproduce behavioural and/or anatomical impairments reminiscent of Huntington's disease (HD), an autosomal dominant hereditary neurodegenerative disease [1] . Among them, administration of 3-nitropropionic acid (3NP), an irreversible succinate dehydrogenase (SDH) inhibitor [2] , appears suitable to reproduce motor, lesional and/or cognitive characteristics of HD both in rodents and non-human primates [1, 3, 4] . Nevertheless, the experimental potential of this model is impeded, especially in rodents, by the interindividual and inter-strain variability observed after systemic 3NP injection [5±7] . Particularly, in Sprague±Dawley rats, several studies reported that acute administration or continuous s.c. infusion of 3NP produces unpredictable occurrence and variable extension of the striatal lesion, variability in the motor impairments and, at the highest doses, extrastriatal lesions and mortality [5,7±9] . Interestingly, Ouary et al. [7] recently demonstrated that the systemic administration of 3NP in the Lewis rat pr1oduces minimal variability in lesion occurrence (100%) and animal susceptibility. However, such a model not only requires predictable occurrence of the lesion but also minimal variation in its quality. In the present study, we therefore further analyzed the location, size and topology of the lesion.
MATERIALS AND METHODS
Adult male Lewis rats (IFFA Credo, France), 12 weeks of age, weighing 320±380 g were housed 3/cage and maintained in a temperature-and humidity-controlled room on a 12:12 h light:dark cycle with food and water ad lib. The number of animals was kept to the minimum and all efforts to avoid animal suffering were made in accordance with the standards of the Institutional Ethical Commitee of the School of Medicine of Universite Â Libre de Bruxelles.
Rats were anaesthetised with a mix containing xylazine hydrochloride (Rompun, Bayer; 4.5 mg/kg) and ketamine hydrochloride (Imalgene, Merial; 90 mg/kg). In the 3NP-treated animals (n 7), an incision was made below the base of the neck and a 2mL1 Alzet osmotic minipump (delivering 10 ìl/h for 7 days ; IFFA Credo, Belgium) containing 3NP was positioned under the skin. 3NP was dissolved at a concentration of 99 mg/ml in PBS 0.1 M (pH 7.4), adjusted to pH 7.2±7.3 with 5 N NaOH. The ®nal concentration of 3NP in the pump was adjusted to the weight of rats the day of implantation in order to deliver exactly 56 mg/kg/day. Sham rats (without minipump implantation; n 7) underwent all the surgical procedures.
Controls and 3NP-treated animals were evaluated every day for both weight loss and motor impairments. For the latter we used a quantitative neurological scale described previously [9] . Brie¯y, behavioural abnormalities were determined according to the presence and the severity of motor symptoms consisting of dystonia (intermittent dystonia of one hindlimb, score 1; intermittent dystonia of two hindlimbs, score 2; permanent dystonia of hindlimbs, score 3), gait abnormalities consisting mainly of an uncoordinated and wobbling gait (score 1), recumbency (animals lying on one side but showing uncoordinated movements when stimulated, score 1; near death recumbency characterized by almost complete paralysis with rapid breathing, score 2). Additionally, the capabilities of animals to grasp a cage grid with forepaws (unable 1) or to remain on a small platform (9 3 5 cm) for more than 10 s (unable 1) was determined.The ®nal neurological score was assessed as the sum of the above individual scores (minimum 0, normal animal; score 8, animal showing near death recumbency).
Five days after implantation, rats were killed by decapitation and their brains were quickly removed. The two cerebral hemispheres were separated and frozen in 2-methylbutane cooled by dry ice (À408C). The tissue was sectioned at 16 ìm on a cryostat (Leitz) and coronal sections were mounted onto poly-L-lysine-coated slides and stored at À208C until use.
Adjacent sections (bregma 1.6 mm and 0.48 mm according to the stereotaxic coordinates of Paxinos and Watson [10] ) were used for either hematoxylin histochemistry or SDH activity determination. Hematoxylin staining was used to determine the surface of the macroscopic lesion area in 3NP-treated animals but also to perform topological recontructions (see below). Measurement of succinate dehydrogenase activity in control and 3NP-treated rats was performed as described previously [8] . Sections were air dried and then incubated for 15 min in 0.1 M PBS (0.9% NaCl) at 378C followed by incubation in 0.3 mM nitroblutetrazolium (Sigma, Belgium), 0.05 M sodium succinate (Sigma, Belgium) and 0.05 M phosphate buffer pH 7.6 and for 30 min at 378C. Finally, sections were rinsed successively in cold PBS for 5 min and in deionized water and dried at room temperature. The image of each section was acquired and the quanti®cation was performed as described previously [8] using NIH image software according to the regions of interest (ROI) presented in Fig. 1a .
Topological analysis of lesions induced by 3NP was performed as described previously [11] . Brie¯y, hematoxylin-stained sections were acquired and the limits of the striatal lesions were precisely drawn as well as the limits of surrounding landmarks such as corpus callosum and lateral ventricle. Drawings from 3NP-treated rats were superimposed using these different landmarks and the center of the lesion core. Once the best overlap was attained, a system of reference, common to these stacked drawings, was de®ned and allowed to keep the orientation of each drawing. For each section, polar coordinates (degree and vector length) of lesion limits and corpus callosum and lateral venticule location were measured in the de®ned reference system every 15(. Vectors were averaged for each angle value obtained on each 3NP-treated animal in order to construct the mean AE s.e.m. limits of the lesion.
All the results were expressed as the mean AE s.e.m. of the considered parameter. Comparison among groups were performed using either one way ANOVA followed by a Bonferronis post-hoc test or unpaired Student's t-test using GraphPad Instat software.
RESULTS
When compared to control rats, 3NP-treated animals demonstrated a progressive weight loss and increasing behavioural abnormalities. Weight loss was estimated each day after osmotic minipump implantation and was shown to decrease signi®cantly from day 4. It reached 85.23 AE 0.86% ( p , 0.0001; unpaired Student's t-test) of untreated controls at day 5. The mean weight loss of each individual treated animal was 17.9 AE 0.86% of his own weight on the day of surgery. Behavioural impairments were obvious 3 days after treatment with a neurological score of 0.71 AE 0.35 and were mainly manifested as intermittent dystonia of one hindlimb. Four days after implantation, all animals were clinically affected (neurological score 2.6 AE 0.3) and mainly shared gait abnormalities and unilateral/bilateral intermittent hindlimb dystonia. Finally, at day 5, all seven animals were alive and clinically affected (neurological score 5.0 AE 0.3). Gait abnormalities were observed in all animals. Permanent dystonia of both hindlimbs and incapability to remain for a short time on the platform was Fig. 2 Topological analysis of the striatal lesions induced by subcutaneous infusion of 3-nitropropionic acid in the Lewis rat. (a) Typical hematoxylin staining in the rat striatum of control or 3NP-treated rats for 5 days (56 mg/kg/day, continuous s.c. infusion). Reconstructions of the mean space of the striatal (Str) lesions delineated by the typical histological staining were performed for seven rats treated with 3NP-treated FOR 5 days (56 mg/kg/day, continuous s.c. infusion) in the stereotaxic planes â1.6 mm (b) and â0.48 mm (c) and for two rats treated for 7 days (56 mg/kg/day, continuous s.c. infusion) in the stereotaxic plane â0.48 mm (e). These reconstructions include the lesion represented as its mean limit (inside of the borderline) and SEM (outside of the borderline), the subjective center of the lesion and the inside border of the corpus callosum (cc). (d) is an alternative representation of the topology drawn in (c) and shows the mean vector length AE s.e.m. (distance from the center to the lesion border) for each considered angle. Dashed line in (e) represents the mean limit of the striatal lesion in the stereotaxic plane â0.48 mm 5 days after minipump implantation as shown in (c). Bars 1 mm. These quantitative data demonstrate that, 5 days after minipump implantation, the striatal lesion reproducibly and primarily locates within the lateral part of the striatum and expand to the medial part 7 days after the begining of 3NP infusion. The predictible location of the striatal lesion observed in this model is great of importance in the ®eld of neuroprotection for Huntington's disease. observed in six of seven rats. The remaining rat presented intermittent dystonia of the two hindlimbs and was unable to remain on the plateform for more than 10 s. The score of untreated animals was always of 0.
After 5 days of 3NP treatment, SDH activity was signi®cantly decreased both in the outer cortex (À59.5 AE 5.5% compared to control) and in the striatum (À81.6 AE 3.6%; Fig. 1b,c) . SDH activity in the lateral and medial parts of the striatum were differentially affected by 3NP: 85.9% inhibition in the lateral and 58.4% inhibition in the medial striatum ( p , 0.05, Bonferroni post-hoc test; Fig.  1b) . Thus, the loss of SDH activity was partial within the cortex and the medial striatum whereas it was strongly decreased in the lateral striatum. Interestingly, the lateral area with the strongest SDH decrease was topologically correlated with the lesioned area according to hematoxylin staining.
In all seven 3NP-treated rats the lesion was located in the lateral part of the striatum (Fig. 2a) with surface areas of 5.13 AE 0.31 mm 2 and 7.52 AE 0.51 mm 2 at the stereotaxic planes â1.6 mm and â0.48 mm, respectively. The lesioned area undergoes intense cell death as assessed using both TUNEL and Fluorojade staining (data not shown). As assessed by the quantitative topological reconstructions, the dorso-ventral extension as well as the location of the lesions was strongly conserved within all the 3NP-treated rats at the two considered stereotaxic planes (Fig. 2b,c) . The periventricular medial area of the striatum as well as the lateral part bording the corpus callosum were spared. Moreover, as shown by the polar representations, the topological reproducibility was highly conserved at every angle measured (Fig. 2d) . Seven days after minipump implantation, the lesioned area progresses towards the medial part of the striatum as assessed by topological data presented in Fig. 2e .
DISCUSSION
In the present study, in addition to the homogeneous appearance of motor symptoms, we observed that 5 days of continuous s.c. infusion of 3NP in the Lewis rat produces a highly reproducible striatal lesion. Interestingly, the maximal variation coef®cient in the measurement of the surface lesion and the vector length was 7% and 12% respectively, pointing out the high reproducible topological location of the lesion. The reasons for such low variability of the 3NP-induced striatal injuries, as compared to other rat strains, are unclear and may be related to the genetic homogeneity of the Lewis inbred strain and/or to the blunted hypothalamus-pituitary axis reactivity as previously suggested by survival assays [7] .
Although the lesioned area progresses reproducibly towards the medial part of the striatum seven days after the 3NP treatment, our histological and SDH data show that the lateral striatum is primarily affected. The reasons for such preferential vulnerability are poorly understood. Although dopaminergic [12] and glutamatergic [3] innervations are known to be strongly involved in the striatal toxicity of the 3NP, other extrinsic factors (cytokines, growth factors, vulnerability of the lateral striatal artery [13] ) could also be implicated, but, at present, none can de®nitively explain the lateral vulnerability. Similarly, intrinsic neuronal factors such as gradient in latero-medial expression of some neuronal receptors (D2, A2a [14, 15] ) may play a role. Whatever, our topological observations are in line with the earliest vulnerability of the dorsal part of the striatum as well as the preferential dorso-lateral orientation of the putaminal lesion previously observed in HD patients [16, 17] , although interspecies anatomical comparison have to be carefully considered.
In conclusion, given its high reproducibility, especially concerning the predictable topology of the lesion, the present model provides a powerful tool to precisely determine the potential bene®ts of neuroprotective strategies in HD.
